Company / EPS (Basic)
Humana EPS (Basic) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
$20.09
FY2025
5-year range
$20.09 / $25.47
FY2021-FY2025
Trend
-9.5%
vs FY2024
Sector context
#8 of 160
Health Care
What the data says
Among 160 Health Care companies, Humana is in the top 5% for eps (basic). EPS (Basic) has declined for 3 consecutive years, from $25.47 in FY2022 to $20.09 in FY2025.
Based on SEC 10-K filings.
20.09 in FY2025 with a 5-year CAGR of +10.4%. Top quartile in the Health Care sector.
Declined from $22.79 to $20.09 over the past 2 years.
Health Care sector context is included.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -7.6%
- 5-Year CAGR
- +10.4%
- 10-Year CAGR
- -
Sector benchmark
Top 5% in Health CareTop 5% of 160This company $20.09 Sector average $2.36
▼
+750.1% above sector average
Key checks
Key Insights
- Humana's eps (basic) has declined for 3 consecutive years.
- In FY2025, eps (basic) decreased 9.5% year-over-year.
- Ranks #8 out of 160 companies in the Health Care sector.
- Peak eps (basic) was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 3.80 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $20.09 | -9.5% |
| FY2024 | $22.20 | -2.6% |
| FY2023 | $22.79 | -10.5% |
| FY2022 | $25.47 | +26.1% |
| FY2021 | $20.20 | +65.0% |
| FY2020 | $12.24 | -27.7% |
| FY2019 | $16.94 | +312.2% |
| FY2018 | $4.11 | -51.9% |
| FY2017 | $8.54 | +14.8% |
| FY2016 | $7.44 | -4.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026